Professional
Added to YB: 2025-02-04
Pitch date: 2025-01-24
MEDP [bullish]
Medpace Holdings, Inc.
+44.41%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
$12.8B
Pitch Price
$343.47
Price Target
N/A
Dividend
N/A
EV/EBITDA
20.52
P/E
29.53
EV/Sales
4.92
Sector
Life Sciences Tools and Services
Category
N/A
Show full summary:
Giverny Capital Asset Management Portfolio Holding: Medpace Holdings, Inc.
MEDP: Clinical trial CRO for early-stage biopharma. 17% insider ownership. Doubled profit in 3 years. Quality scientific work & client selection. Concerns over RFK Jr.'s HHS nomination impact pharma. PE 27x, below historical norm. $11B market cap.
Read full article (1 min)